Explicyte intensifies its efforts in translational research & will be attending the ASCO Annual Meeting 2019 in Chicago
05 / 21 / 2019
By setting new facilities within the cancer center “Institut Bergonié”, Explicyte - in addition to its preclinical research capabilities - strengthens its development towards clinical translational research, to provide new services based on multiparametric experimental biomarker analysis, for target identification and monitoring of the immune response in the context of clinical trials.